跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Trilipix Modified Release Capsules 135mg - HSA Drug Approval Details
Approvals
/
HSA
/
Trilipix Modified Release Capsules 135mg
Approved
STANDARD
Trilipix Modified Release Capsules 135mg
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
65fbcd0a218fc1ac
Company
Unknown
Type
Standard
Approval Details
Approval Id
65fbcd0a218fc1ac
Drug Name
Trilipix Modified Release Capsules 135mg
Active Ingredients
Choline Fenofibrate 178.8mg eqv Fenofibric Acid
135mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
65fbcd0a218fc1ac
Type
Standard
Back to HSA Approvals